Our previous results suggested that mesothelin might be a good target for control by an immune response [7], as mesothelin overexpression reliably caused a decrease in a heterotopic tumor growth in an immunocompetent syngeneic mouse model while in vitro proliferation was not inhibited [7]. Here, MSLN is linked to neoplasm.